Table 3

Regional blood flow and oxygen delivery during infusion of vasopressin in non-septic animals

Time

300 minutes
360 minutes
480 minutes

Portal vein (mL/kg per minute)a,b





Group C
33 ± 3
32 ± 5
30 ± 4

Group V
33 ± 8
23 ± 4c
25 ± 4c
Hepatic artery (mL/kg per minute)a





Group C
3.2 ± 1.7
3.4 ± 1.7
3.7 ± 1.7

Group V
4.4 ± 1.6
8.2 ± 3.1c
8 ± 2.5c
MBF liver (percentage)





Group C
133 ± 53
135 ± 61
122 ± 57

Group V
85 ± 22
75 ± 38
77 ± 44
MBF kidney (percentage)a





Group C
96 ± 14
94 ± 20
96 ± 20

Group V
106 ± 15
86 ± 16c
105 ± 15
MBF pancreas (percentage)a





Group C
119 ± 14
108 ± 18c
99 ± 17c

Group V
110 ± 30
74 ± 15c
76 ± 23c

A continuous infusion of vasopressin (0.06 IU/kg per hour) was started at t = 300 minutes in group V. Animals in group C received intravenous saline only.

ap < 0.01 time-group interaction groups V versus C: effect of vasopressin in control animals.

bp < 0.05 Mann-Whitney test (area under curve): effect of vasopressin in non-septic versus septic animals.

cp < 0.01 compared to t = 300 minutes.

Group C: non-septic control group. Group V: non-septic vasopressin control group. Hepatic artery: blood flow in the hepatic artery. MBF kidney: microcirculatory blood flow in the renal cortex. MBF pancreas: microcirculatory blood flow in the pancreas. MBF was measured by laser Doppler flowmetry and expressed as percentage of baseline. Portal vein: blood flow in the portal vein.

Krejci et al. Critical Care 2007 11:R129   doi:10.1186/cc6197